Clinical Trial Update: Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia

View source ↗

Summary

Non-interventional study evaluating home administration of the filgrastim biosimilar Nivestim for primary prophylaxis of chemotherapy-induced febrile neutropeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Febrile Neutropenia
• Febrile Neutropenia

Drugs mentioned

• Nivestim (filgrastim)

Snippet

Sponsor: Pfizer | Conditions: Non-Interventional Study | Status: COMPLETED | Results posted: 2019-02-11